Omnicell, Inc. (OMCL)

NASDAQ: OMCL · USD

$35.9

-0.83 (-2.3%)· Recorded snapshot

Market cap	1.6B
Revenue (ttm)	1.2B
Net income (ttm)	39.1M
EPS (ttm)	$0.84
Shares out	45.6M
P/E (trailing)	42.7x
P/E (forward)	20.2x
Volume	707,814
Beta	0.99

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.2B
Net income (ttm): 39.1M
EPS (ttm): $0.84
P/E (trailing): 42.7x
P/E (forward): 20.2x
Market cap: 1.6B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E20.2

P25 n/aP50 n/aP75 n/a

Trailing P/E42.7

P25 n/aP50 n/aP75 n/a

ROE3.1

P25 n/aP50 n/aP75 n/a

ROIC2.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All OMCL indicators

Market & fundamental data

Available fields

274

Groups with data

Currency

USD

Showing 274 of 274 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000926326
Company name	Omnicell, Inc.
Country	United States
Country code	US
CUSIP number	68213N109
Earnings date	2026-10-29
Earnings time	bmo
Employees	3,485
Employees change	-165
Employees growth	-4.52%
Enterprise value	$1.5B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1992
In index	RUSSELL2000
Industry	Health Information Services
IPO date	2001-08-07
Is primary listing	Yes
Is SPAC	No
ISIN number	US68213N1090
Last 10-K release date	2026-02-26
Last earnings date	2026-07-30
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$1.6B
Market cap category	Small-Cap
Next earnings date	2026-10-29
Options	Yes
Price	$35.93
Price currency	USD
Sector	Healthcare
SIC code	3571
Stock price date	2026-10-28
Symbol	OMCL
U.S. state	Texas
Website	https://www.omnicell.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	14.97x
Average P/E ratio (10Y)	124.97x
Average P/E ratio (5Y)	177.61x
Earnings yield	2.34%
EV/Earnings	40.58x
EV/EBIT	31.43x
EV/EBITDA	19.3x
EV/FCF	11.32x
EV/Sales	1.27x
FCF / EV yield	8.84%
FCF yield	8.35%
Forward EV/Sales	1.27x
Forward P/E	20.18x
Forward P/S	1.34x
Graham number	23.15413
Graham upside	-37.06%
Industry forward P/E	35.4x
Lynch fair value	$4.21
Lynch upside	-88.56%
P/(FCF - SBC) ratio	17.61x
P/(OCF - SBC) ratio	12.29x
P/B ratio	1.3x
P/E ratio	42.7x
P/FCF ratio	11.97x
P/OCF ratio	9.25x
P/S ratio	1.35x
PEG ratio	0.74x
Price / tangible book value	4.91x
Price/EBITDA ratio	20.42x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	4.05%
EBITDA margin	6.59%
Effective tax rate	36.08%
FCF margin	11.24%
Gross margin	44.01%
Operating margin	4.05%
Pretax margin	4.9%
Profit margin	3.13%
Profit per employee	$11,215
Profitable quarters	2
Profitable years	2
Revenue per employee	$357,734
ROA	1.52%
ROA (5Y)	0.79%
ROCE	3.25%
ROE	3.06%
ROE (5Y)	1.46%
ROIC	2.67%
ROIC (5Y)	1.91%
SBC / revenue	3.6%
Tax / revenue	1.77%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	70.73%
EPS growth (Q)	333.33%
EPS growth (QoQ)	108%
EPS growth 10Y	7.88%
EPS growth 5Y	-8.67%
EPS growth quarters	2
EPS growth years	0
FCF growth	31.19%
FCF growth (Q)	91.69%
FCF growth (QoQ)	41.15%
FCF growth 3Y	-0.15%
FCF growth 5Y	-8.76%
Gross profit growth	9.95%
Gross profit growth (Q)	8.82%
Gross profit growth 3Y	0.04%
Gross profit growth 5Y	2.74%
Net income growth	69.28%
Net income growth (Q)	330.73%
Net income growth (QoQ)	113.85%
Net income growth 5Y	-8.13%
Net income growth quarters	2
Net income growth years	0
OCF growth	22.8%
OCF growth (Q)	59.78%
OCF growth (QoQ)	25.35%
OCF growth 10Y	16.19%
OCF growth 3Y	-1.35%
OCF growth 5Y	-5.62%
Operating income growth	318.78%
Operating income growth (Q)	127.2%
Operating income growth 5Y	-10.4%
Revenue growth	8.45%
Revenue growth (Q)	7.45%
Revenue growth (QoQ)	0.75%
Revenue growth 10Y	7.6%
Revenue growth 3Y	0.31%
Revenue growth 5Y	4.77%
Revenue growth quarters	7
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-41.3M
Depreciation and amortization	$31.7M
EBIT	$50.5M
EBITDA	$82.2M
EPS	$0.84
FCF per share	$3.07
Financing cash flow	$-231.9M
Free cash flow	$140.2M
Free cash flow minus SBC	$95.3M
Gross profit	$548.7M
Income taxes	$22.1M
Investing cash flow	$-57.1M
Net borrowing	$-175M
Net cash flow	$-108.7M
Net income	$39.1M
Operating cash flow minus SBC	$136.5M
Operating income	$50.5M
Revenue	$1.2B
Stock-based compensation	$44.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.61
Book value per share	$28.32
Debt / EBITDA	2.17
Debt / equity	0.15
Debt / FCF	1.43
Goodwill	$737.2M
Interest coverage	12.62
Long-term assets	$1.3B
Long-term liabilities	$259.8M
Net cash (debt)	$92.2M
Net cash / market cap	5.49%
Net cash growth	531.55%
Net debt / EBITDA	-1.12
Net debt / equity	-0.07
Net debt / FCF	-0.66
Piotroski F-Score	7
Property, plant and equipment	$143.5M
Shareholders' equity	$1.3B
Tangible book value	$341.7M
Tangible book value per share	$7.49
Total assets	$2B
Total cash	$292.2M
Total debt	$200M
Total liabilities	$707.3M
WACC	8.78%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.6
Current assets	$735.4M
Current liabilities	$447.4M
Current ratio	1.64
Inventory turnover	6.89
Net working capital	$7.3M
Quick ratio	1.19
Working capital	$287.9M
Working capital turnover	4.63

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.28%
Dividend yield	0%
Shareholder yield	1.28%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	3.25%
10Y return CAGR	0.32%
10Y total return	3.25%
150-day SMA	$38.36
15Y price change	113.62%
15Y return CAGR	5.19%
15Y total return	113.62%
1D price change	-2.26%
1M price change	6.74%
1M total return	6.74%
1W price change	-1.13%
1W total return	-1.13%
1Y price change	17.65%
1Y return CAGR	17.66%
1Y total return	17.65%
20-day SMA	$35.81
200-day SMA	$39.18
20Y price change	94.32%
20Y return CAGR	3.38%
20Y total return	94.32%
3M price change	-13.4%
3M total return	-13.4%
3Y price change	3.1%
3Y return CAGR	1.02%
3Y total return	3.1%
50-day SMA	$34.57
50-day SMA vs 200-day SMA	50under200
52-week high	$55.00
52-week high date	2026-01-13
52-week low	$29.09
52-week low date	2025-10-29
5Y price change	-78.62%
5Y return CAGR	-26.55%
5Y total return	-78.62%
6M price change	-4.52%
6M total return	-4.52%
All-time high	$187.29
All-time high date	2021-11-22
All-time low	$1.29
All-time low date	2002-10-17
Average true range (ATR)	$1.26
Average volume	478K
Beta (1Y)	1.36
Beta (2Y)	0.92
Beta (5Y)	0.99
Change from 52-week high	-34.67%
Change from 52-week low	23.51%
Change from all-time high	-80.82%
Change from all-time low	2,685.27%
Change from open	-2.12%
Day's gap	-0.14%
Dollar volume	$25.4M
High price	$37.21
Low price	$35.56
Monthly RSI	45.84
Open price	$36.71
Position in 52-week range	22.42%
Premarket change	-3.29%
Premarket close	$36.76
Premarket price	$35.55
Previous close	$36.76
Price vs 150-day SMA	-6.34%
Price vs 20-day SMA	0.34%
Price vs 200-day SMA	-8.29%
Price vs 50-day SMA	3.93%
Relative volume	1.53
RSI	51.71
Sharpe ratio	0.49
Sharpe ratio (3Y)	0.15
Sharpe ratio (5Y)	-0.42
Sortino ratio	0.88
Sortino ratio (3Y)	0.35
Sortino ratio (5Y)	-0.49
Volume	707.8K
Weekly RSI	47.71
YTD price change	-20.68%
YTD total return	-20.68%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	44.4M
Float percentage	97.29%
Shares change (QoQ)	0.78%
Shares change (YoY)	-1.28%
Shares held by insiders	2.67%
Shares held by institutions	109.19%
Shares outstanding	45.6M
Short % of float	8.2%
Short % of shares	7.98%
Short ratio	6.1 days

Deeper analysis on OMCL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this OMCL report

Is a complete OMCL research report available?

No complete published report is available for Omnicell, Inc. (OMCL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Omnicell, Inc. (OMCL)

Price

Financial snapshot

Fair-value bridge

Latest news · OMCL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All OMCL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on OMCL

Frequently asked questions